This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
$0.03000
Share price
0.00%
Change (1 day)
-94.92%
Change (1 year)
Categories
EPS for Advaxis (ADXS)
EPS in 2023 (TTM): -$5.97
According to Advaxis's latest financial reports the company's current EPS (TTM) is -$5.97. In 2021 the company made an earnings per share (EPS) of -$2.83 a decrease over its 2020 EPS that were of -$2.60.
EPS history for Advaxis from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.97 | |
| 2021 | -$2.83 | 8.65% |
| 2020 | -$2.60 | 25.61% |
| 2019 | -$2.07 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$0.65 | -89.11% | 🇺🇸 USA |
 | -$0.52 | -91.29% | 🇺🇸 USA |
 | -$1.93 | -67.67% | 🇺🇸 USA |